Epidemiology of Diabetes Mellitus in Asia

Similar documents
The Metabolic Syndrome: Is It A Valid Concept? YES

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

The Epidemiology of Diabetes in Korea

COSTS OF DIABETES IN DEVELOPING COUNTRIES

DIABETES. A growing problem

FRANKFURT SITE TOUR 2017

Diabetes Management and Considerations for the Indian Culture

Biomarkers and undiagnosed disease

The Diabetes Epidemic in Korea

Non communicable Diseases

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

Cigarette Consumption in China ( ) Cigarette Consumption in Poland ( )

BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS

D. Hilton. Keywords Epidemiological methods, aging, prevalence.

Diabetes management: lessons from around the globe Romania. S. Popa (Romania)

Why Do We Treat Obesity? Epidemiology

Health outcomes & research objectives in (crosscultural)international

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

CLINICAL PROFILE OF TYPE 2 DIABETES

The Diabetes Pandemic

GLOBAL VALUE DOSSIER FOR BARIATRIC SURGERY

Ketut Suastika. Faculty of Medicine, Udayana University< Denpasar, Bali, Indonesia

Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults

Asia s Diabetes Challenge

Identification of subjects at high risk for cardiovascular disease

Type 2 diabetes, the metabolic syndrome and cardiovascular disease in Europe

Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS

Obesity, Metabolic Syndrome, and Diabetes: Making the Connections

Diabetes management: lessons from around the globe MENA. J. Belkhadir (Morocco)

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Roadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Young Seok Song 1, You-Cheol Hwang 2, Hong-Yup Ahn 3, Cheol-Young Park 1

Plasma concentrations of afamin are associated with the metabolic syndrome and related diseases

The Global Agenda for the Prevention of Diabetes: Research Opportunities

Metabolic Syndrome in Asians

GLOBAL BURDEN OF DIABETES

METHODS AND MATERIALS

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

National Health & Morbidity Survey 2015; NCD Risk Factors

East Carolina University Continuing Education Courses for Sustainability Symposium

The epidemiology of tuberculosis

China s Health Reform, Chronic Disease Burden and the Elderly

Obesity in South Korea

Why Do We Care About Prediabetes?

DM and TB Double Burden. Anil Kapur

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome

Physical Activity: Impact on Morbidity and Mortality

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Type 2 Diabetes in Adolescents

GLOBAL HIV STATISTICS

International Journal of Health Sciences and Research ISSN:

Place matters: why cities are key to ending AIDS

Characteristicsof Glucose Disposal Index in General Population in China

Primary Prevention of T2DM. KW Chan Endocrine & Diabetes Team Department of M&G, PMH 22 March 2009

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Lifestyle Medicine. This presentation will:

the African scenario

The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine

HIV in Myanmar. HIV in Myanmar. Outline. Socio-economic context Epidemiology HIV cascade Testing Treatment Barriers Conclusions 21/02/2017

METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS

A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China

Obesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea

Continua Health Alliance Industry Statistics

Prevalence of Diabetes Mellitus and Pre-Diabetes in the Philippines: A Sub-study of the 7 th National Nutrition and Health Survey (2008)

Hypertension Management in Diabetic Patients

SCIENTIFIC STUDY REPORT

Pre-diabetes. Dr Neel Basudev. GPSI Lambeth DICT, Diabetes Lead Lambeth CCG

American Academy of Insurance Medicine

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group

DECLARATION OF CONFLICT OF INTEREST. none

OBESITY IN PRIMARY CARE

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Diabetes Care 34: , 2011

A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom

Burden and measurement of Noncommunicable diseases

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

A COMPARATIVE EVALUATION OF HBA1C MEASUREMENT IN DIFFERENT ANTICOAGULANT VIALS AND ITS STABILITY ON STORAGE

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y

Assessment of the Metabolic Syndrome in Predicting Incident Type 2 Diabetes in a Chinese Population. Jianjun Wang

THE HEALTH AND ECONOMIC THREATS OF NON-COMMUNICABLE DISEASES IN THE MIDDLE EAST AND NORTH AFRICA, CV BoD in Egypt/ MENA

5/28/2010. Pre Test Question

Global, National, Regional

TB epidemic and progress towards the Millennium Development Goals

Dr. Lancelot Mui, MPH Post-doctoral Fellow School of Public Health and Primary Care The Chinese University of Hong Kong

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with

USE OF MACHINE LEARNING TO PREDICT THE ONSET OF DIABETES

Diabetes is a condition with a huge health impact in Asia. More than half of all

Tackling the epidemic of chronic noncommunicable disease in sub Saharan Africa: established priorities and new concerns

300 Biomed Environ Sci, 2018; 31(4):

A simple screening score for diabetes for the Korean population

for the Management of Chronic Disease

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Practical Diabetes. Nic Crook. (and don t use so many charts) Kuirau Specialists 1239 Ranolf Street Rotorua. Rotorua Hospital Private Bag 3023 Rotorua

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Transcription:

Epidemiology of Diabetes Mellitus in Asia Nam H. Cho Professor of Preventive Medicine Director of Clinical Epidemiology Ajou University School of Medicine and Hospital, Suwon Korea President-elect of International Diabetes Federation Program Chairman of 2017 Abu Dhabi WDC Chairman of IDF Diabetes Atlas Committee

DIABETES A GLOBAL epidemic out of control Diabetes is a culture-social structural disease

IDF Diabetes Atlas, 7 th edition Estimated number of people with diabetes worldwide and per region in 2015 and 2040 (20-79 years) IDF Diabetes Atlas, 7 th edition World 2015 415 Million 266.0 M (64.3%)

Top 10 countries Top ten countries/territories for number of people with diabetes (20-79 years), 2015 and 2040 178.8M=43% 37.5% 78.5% IDF Diabetes Atlas, 7 th edition

Diabetes prevalence by IDF region IDF regions by age-adjusted comparative prevalence (%) of diabetes (20-79 years), 2015 and 2040 AFR Africa region EUR European region MENA Middle East and North African region WP West Pacific region NAC North American and Caribbean region SACA South and Central American region SEA South East Asia region IDF Diabetes Atlas, 7 th edition

and the costs to society are high and escalating Diabetes is a human and economic burden 4.9 million deaths Intersects with all dimensions of development 11% worldwide expenditure IDF Diabetes Atlas, 6 th edition, 2013

and the costs to society are high and escalating Diabetes is a human and economic burden 5 million deaths Intersects with all dimensions of development 12% worldwide expenditure IDF Diabetes Atlas, 7 th edition, 2015

Western Pacific Region IDF Diabetes Atlas, 7 th edition

The prevalence of diabetes by age in the International Diabetes Federation Western Pacific Region 153.2 million Observed 19.5 51.4 million Excess 11.5 101.8 million Expected

Europe IDF Diabetes Atlas, 7 th edition

The prevalence of diabetes by age in the International Diabetes Federation Europe 59.8 million Observed 39.6 million Excess 20.2 million Expected

The prevalence of diabetes by age in the International Diabetes Federation WPR VS EUR

Undiagnosed diabetes Proportion and number of people (20-79 years)living with diabetes who are undiagnosed, 2015 IDF region Proportion undiagnosed Number of undiagnosed people with diabetes IDF Diabetes Atlas, 7 th edition

Western Pacific

12% of global health expenditure is spent on diabetes

Health Expenditure on diabetes Proportion of total health expenditure estimated to be spent on diabetes (20-79 years), R=2*, 2015 *The R=2 estimates assume that healthcare expenditures for people with diabetes are on average twofold higher than people without diabetes AFR Africa region EUR European region MENA Middle East and North African region WP West Pacific region NAC North American and Caribbean region SACA South and Central American region SEA South East Asia region IDF Diabetes Atlas, 7 th edition

IDF Diabetes Atlas, 7 th edition

Identification of high risk population using the risk factors

Cox Proportional Hazard Analysis of T2DM:at 14 yrs FU Variables ß p-value RR(95% C.I.) Mets 0.438 <0.001 1.55(1.28~1.87) Urban 0.698 <0.001 2.01(1.70~2.38) NGT Reference IFG 1.213 <0.001 3.36(2.35~4.81) IGT 1.537 <0.001 4.65(3.95~5.48) IFG+IGT 2.335 <0.001 10.33(6.99~15.26) Normal Reference Pre hypertension 0.266 0.004 1.30(1.09~1.57) HTN stage1 0.120 0.386 1.13(0.86~1.48) HTN stage2 0.582 <0.001 1.79(1.40~2.29) Non-smoker Reference Ex-smoker 0.219 0.038 1.24(1.01~1.53) Current smoker 0.578 <0.001 1.78(1.49~2.14) Family History of DM 0.384 0.001 1.47(1.18~1.83) Physical stress signs 0.483 0.011 1.62(1.12~2.35) Age 0.025 <0.001 HbA1c 1.803 <0.001 Composite Insulin Sensitivity Index -0.013 0.011 Insulinogenic index -0.001 0.017 ALT 0.007 <0.001 Adjusted for sex, alcohol drinking, exercise,, Quicki index, WBC, RBC

US $ Trend of T2DM in Korea Economy vs. Prevalence Prevalence rate(%) Cho NH. Journal of Diabetes Investigation 2013

Diabetes in urban and rural environments 65% 74.5% IDF Diabetes Atlas, 7 th edition

Baseline Smoking Status and T2DM Status during 12 yrs of Follow-up *** * * *** ** RR <0.05, **<0.01, ***<0.001; Adjusted for Sex, Fam Hx DM, Residence, Exer,, Alcoh, age, SBP, WC, WBC, RBC, T.Chol, HDL, Tg, ALT, HbA1c, Beta cell function, HOMA-IR, Quicki index Cho NH et al. Clin Endocrinol. 2009 Nov;71(5):679-85.

Diabetes in Old population

Medical Expenses in age 65 yrs Billion $ 25 20 15 10 10.74 12.42 14.14 15.39 16.45 18.57 19.86 21.92 5 (30.8) (31.6) (32.4) (33.3) (34.4) (35.4) (36.6) (37.8) 0 2008 2009 2010 2011 2012 2013 2014 2015 % old pop. 10.3 10.7 11 11.4 11.8 12.2 12.7 13.1

Million Frequency of Diabetes in Older population 65+ yrs

Multiple Logistics Analysis of Old population variables ß p-value OR(95% C.I.) 65 yr 0.687 <0.001 1.99(1.65~2.39) Male 0.471 0.012 1.60(1.11~2.31) Urban 1.200 <0.001 3.32(2.73~4.03) Non-Smoker Reference Past Smoker 0.298 0.027 1.35(1.03~1.76) Current Smoker 0.054 0.725 1.06(0.78~1.43) Family Hx DM 0.531 <0.001 1.70(1.40~2.07) Waist -0.012 0.046 ASM/Wt -0.056 0.007 sbp 0.011 <0.001 HbA1c 2.313 <0.001 HOMA-IR 0.604 <0.001 β-cell function -0.015 <0.001 T.Chol --0.010 <0.001 Tg 0.001 0.020 Constant -12.675 <0.001 Adjusted for alcohol drinking, exercise, ALT, Quicki index, HDL

Diabetes in High risk population

% Status of pre-diabetes 12 yrs follow-up

Cumulative Incidence of T2DM 12 yrs follow-up 90 IFG IGT IFG+IGT 80 70 60 % 50 40 30 20 10 0 2yr 4yr 6yr 8yr 10yr 12yr

Trend of IGT 481 M 318 M 352 M 2015 2017 2040 Year * 5+ were exclude because 198 out of 207 presented with DM at the baseline examination

Cox Proportional Hazard Analysis of PreDM Variables ß p-value RR(95% C.I.) Urban 0.447 <0.001 1.56(1.31~1.86) SBP 0.011 <0.001 Waist Circumference 0.018 <0.001 T.chol -0.003 0.004 Family History of DM 0.384 0.001 1.41(1.14~1.74) WBC 0.069 0.001 HbA1c 1.221 <0.001 Composite Insulin Sensitivity Index -0.204 0.021 Insulinogenic index -0.147 <0.001 ALT 0.005 <0.001 Adjusted for Age, sex, alcohol drinking, exercise, smoking, Tg, HDL, CRP, Creatinine, Stress

Summary/Conclusion No disease has impacted human life stronger than Diabetes, and Diabetes Epidemic is more serious in Asia than any part of the world. Costs are greater than any other diseases. Diabetes is currently unstoppable, but utilization of risk factors for undiagnosed cases and identification in high risk populations accompanied with early management may be the solution and the best way to stop the diabetes Tsunami in Asia.